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The realization that antibody-forming cells descend from bone marrow precursors 
(1-3),  and  that  complex  interactions  between  thymus-  and  marrow-derived  cells 
precede antibody formation  (1-6),  gave impetus to  attempts aimed at establishing 
which cell type was antigen specific (7-12). The issue is of great importance; should 
one of the cell types cooperating in  an immune response be differentiated so as  to 
react  with  a  restricted number  of  antigenic  determinants,  this  cell could perhaps 
dictate the specificity of immunoglobulins synthesized by marrow-derived immuno- 
cytes. On  the other hand,  if cells of thymic and marrow origin were both antigen- 
specific, cell-to-cell interactions would probably not  occur at  random  but  between 
cells sharing receptors of appropriate specificity. 
Results  of  several cell transfer  experiments indicated that  antigen-reactive cells 
(ARC)  1 from mouse thymus or their progeny cells were antigen specific. The evidence 
was  obtained either  by  sensitizing (10-12)  or  by paralyzing (7-9)  thymus-derived 
cells prior to their interaction with marrow cells. Both induced changes of reactivity 
were specific. In contrast, potentially immunocompetent marrow cells were neither 
paralyzed nor sensitized upon exposure to antigens under the same experimental con- 
ditions (8-11).  The failure to  specifically alter the reactivity of marrow cells could 
have been due to nonexistence of antigen-specific cells in this tissue. However, it was 
also possible that such a  cell existed but went undetected because it lacked a role in 
the establishment of tolerance or could not be sensitized upon short-term cell transfer. 
In the experiments to be described, hemolytic plaque-forming cells (PFC) in- 
duced  by  antigens  of  sheep  or  chicken  erythrocytes  (SRBC,  CRBC)  were 
studied  in  irradiated mice  reconstituted  with  excess  thymocytes  and  small, 
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graded numbers  of bone marrow cells. While thymus  donors  were always non- 
immune  mice,  marrow  cell  donors  were  either  nonimmune  or  SRBC-primed 
mice. The results of limiting dilution assays differed markedly for responses to 
SRBC and CRBC  by cells of untreated donor animals. Responses to SRBC by 
marrow cells of immune and nonimmune donors also differed in several respects. 
The induced changes in anti-SRBC responses were detectable for several months 
after  immunization  during  which  responses  to  antigens  of  CRBC  were  not 
altered.  It was,  therefore,  apparent  that  mouse marrow  contained  cells which 
were antigen specific and antigen sensitive. 
Materials and Methods 
Mice.--(C3H/He X  C57BL/Ha)F1 females, 7-10 months old,  and  (C3H/He X  C57BL/ 
10Cz)F1 females, 6-7 months old, were used as donors of bone marrow cells. The abbreviated 
designations for the two hybrid strains are C3BF1 and C3B10F1,  respectively. In all experi- 
ments,  the donors of thymocytes were 2-month  old C3B10F1  mice, and  the irradiated  re- 
cipients  were  3-month  old  C3B10F1  mice.  Preliminary  tests  indicated  that  transplanted 
C3BF1 marrow cells were as effective as C3B10F1  cells in generating PFC in C3B10F1 re- 
cipients. 
Irradiation.--Mice were exposed  to  750-850  R  of total body X-irradiation,  as described 
elsewhere (13), a few hours prior to marrow and thymus cell transplantation. 
Cell Suspensions and Transplantation.--Nucleated bone marrow cells and  thymocytes of 
normal or immunized mice were suspended in Eagle's medium, counted, and injected into a 
lateral tail vein of irradiated mice, as previously described (13, 14). 
Immunization.--Prospective marrow  donors were injected intravenously at the age of 2 
months, with either 3.5  )<  106 or 5 X  l0  s SRBC. The erythrocytes were washed three times 
in calcium and  magnesium-free phosphate-buffered saline,  pH 7.2, and suspended in Eagle's 
medium.  Several months  after immunization, bone marrow cells were harvested,  mixed in 
vitro with thymocytes of nonimmunized donors,  and transplanted  into irradiated recipients. 
1 day  later,  these  recipients were injected intravenously with  5  X  108  washed  SRBC  or 
CRBC. Fresh erythrocytes in Alsever's solution were purchased from Colorado Serum Co., 
Denver, Col., or from Grand Island Biological Co., Microbio Lab, Madison, Wis. 
Assays for Plaque-Forming Cells.--The number of PFC  in spleens of irradiated,  reconsti- 
tuted mice was determined by the Jerne hemolytic plaque method in gel, as modified for use 
with glass microscope slides  (15-17).  Agarose (L'Industrie Biologique Francaise S.A., Genne- 
villiers, France, lot No. 9822), 0.5% in Eagle's minimal essential medium with Hank's salts, 
0.4 ml; erythrocytes, 10%, 0.05 ml; and the spleen cell suspensions,  0.1 or 0.2 ml, were mixed 
with the aid of a Vortex mixer at 44°C  in 10 X  75 mm tubes and poured onto microscope 
slides. The slides were previously dipped into 0.1% agarose in water and dried. 
Portions  of recipient spleens,  each amounting  to one- or two-tenths  of the organ,  were 
plated on a  minimum of four slides  for duplicate enumeration of direct and  indirect PFC. 
After solidification,  the slides were inverted and placed on special trays (16). For development 
of direct PFC  (presumably releasing IgM antibody)  the slides  were kept  1 hr at 37°C  in a 
humid atmosphere containing 5% CO2. Guinea pig complement (Grand Island Biological Co., 
Grand Island, N. Y.), diluted  1:10 in Eagle's medium, was added and incubation was con- 
tinued for 2 hr.  For facilitation of indirect PFC  (presumably releasing IgG antibody),  the 
slides were kept for the 1st hr as indicated above. Polyvalent rabbit or goat anti-mouse gamma 
globulin antisera  (Cappel  Laboratories,  Downingtown, Pa., and  Hyland Laboratories,  Los 
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direct PFC and maximum development of indirect PFC. After another hour of incubation, the 
slides were transferred to a clean tray, diluted guinea pig complement was added, and incuba- 
tion was  continued for  another 3  hr  (anti-SRBC  plaques)  or  4  hr  (anti-CRBC  plaques). 
Developed slides were fixed  by immersion for 15 mill into 5% glutaraldehyde in water. The 
slides were then rinsed three times in tap water and dried at 45°C.  Plaques were counted at 
7 X  magnification with direct or indirect illumination. 
As the antiglobulin sera used partially inhibited the development of direct PFC, corrections 
were necessary to calculate the number of indirect PFC in each slide  (total number of PFC 
minus noninhibited direct PFC).  Correction factors were applied according to Worfis et al. 
(18).  The average PFC  count per spleen fraction sampled, i.e.  0.1  or 0.2 of the organ, was 
multiplied by 10 or 5, respectively, to calculate the number of PFC per spleen. 
Experimental Design and Statistical Methods.--The Poisson model was used to describe the 
theoretical probability that given numbers of marrow cells would produce PFC in limiting 
dilution assays. Marrow cells were transplanted along with 5 X  107 thymocytes to ensure that 
only the former cells would limit immune responses. The method of maximum likelihood was 
used to estimate probability values and 95% confidence intervals, as described in preceding 
publications  (13,  14).  The  computations and  construction of  theoretical limiting  dilution 
curves were made with the aid of an IBM  1130  computer. Whenever the results were not 
adequately described by the Poisson model,  the  "sign" test  (19)  was used to  compare the 
proportions of responses detected by the direct and indirect plaque methods. 
RESULTS 
Frequency of Anti-Sheep PFC Responses in Mice Injected with Graded Numbers 
of Marrow Cells.- 
Groups of C3B10F1 mice were exposed to whole body X-irradiation and injected with a 
mixture of cells consisting of 5  X  107 syngeneic thymocytes  (from nonimmune donors) and 
graded numbers of C3BF1 or C3B10F1 marrow cells,  in a range extending from 8  X  103 to 
4  X  107. The thymocytes provided each recipient mouse with a nonlimiting number of ARC 
(11).  Marrow cells were  taken from  three different groups of donors: nonimmune mice, or 
mice injected 4-8 months earlier with either 3.5 X  106 or 5  X  l0  s SRBC.  1 day after trans- 
plantation of the cells,  each animal was given 5  X  l0  s SRBC.  Direct and indirect PFC  of 
recipient spleens were enumerated 9 days after transplantation, at the time when peak num- 
bers of PFC are generated by transferred marrow and thymus cells (20). Spleens of 85 control 
mice injected with antigen and  either marrow cells or  thymoeytes,  contained a  small but 
variable number of PFC,  not  exceeding  150.  The variability was primarily related  to  the 
number of marrow cells transplanted and to previous exposure of marrow donors to SRBC. 
Spleens of experimental mice were regarded as positive if the number of PFC exceeded the 
highest number found in control mice. Even after immunization of donors with 5 X  l0  s SRBC, 
marrow cells interacted synergistically with thymocytes in generating PFC.  The results are 
presented in Table I  and Fig. 1. 
A  total of  112 mice were grafted with marrow  cells from nonimmnne  C3BF1 
donors in two experiments. The  donors' age was matched  with that  of immu- 
nized mice  to  be used  in subsequent  experiments.  As  the number  of  marrow 
cells was increased, the proportion of recipients with positive spleens  increased 
for both  direct  and indirect PFC  (upper  sections of Table I  and Fig.  1).  The 
relationship between these two variable parameters did not conform to the pre- 
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less  than  104  marrow  cells  were  grafted.  However,  upon  transplantation  of 
higher numbers of cells, the increase in frequencies of PFC  response was less 
than expected under the assumption that a  homogeneous population of poten- 
tially immunocompetent marrow cells participated in, and limited a  single-hit 
event. Direct PFC responses  were consistently  more frequent than indirect PFC 
TABLE I 
Percentage  of Recipient Spleens Positive for Anti-Sheep PFC After Infusion of 5 X  I0  z 
Thymocytes, 5 X  10  s SRBC, and Graded Numbers of Marrow Cells 
Direct PFC  Indirect PFC 
No. of marrow  Percentage  of  cells transplanted  Percentage  of  No. of PFC per  No. of PFC 
positive spleens*  positive spleen~  positive  per positive  spleens~  spleens* 
(X 10  5) 
Nonimmune marrow donors 
0.08  29  (14)§  300  7  465 
0.31  50  (18)  433  -4-  70  28  141 
0,62  70  (10)  311  -4-  26  20  255 
1,25  82  (17)  444  4-  279  29  452 
2,50  85  (13)  489  4-  105  38  246 
5,00  100  (22)  466  4-  61  50  230 
10.00  94  (18)  457  4-  78  67  200 
Marrow donors immunized with 3.5 X  10  G 
0.31  13  (16)  1035 
0.62  25  (28)  1304  4-  487 
1.25  57  (27)  456  4-  109 
2.50  73  (34)  628  4-  113 
5.00  87  (30)  421  4-  62 
10.00  88  (27)  720  4-  226 
20.00  91  (33)  720  4-  133 
40.00  100  (11)  612  .4-  178 
Marrow donors immunized with 5 X  108 
0.62  0  (10)  -- 
1.25  0  (14)  -- 
2.50  17  (18)  404 
.5.00  13  (17)  497 
10.00  16  (31)  327 
20.00  61  (23)  493  ±  183 
40.00  90  (10)  535  -4-  287 
4-  72 
4-  116 
SRBC 
13  794 
25  520 
41  200  d-  59 
47  282  q-  135 
50  246  4-  96 
70  373  -4-  146 
71  294  ±  110 
73  266  ±  165 
SRBC 
10  165 
27  371 
67  576  .4-  174 
74  744  .4-  252 
87  4-65  .4-  190 
87  624  .4-  181 
90  974  -4-  238 
* For  marrow  grafts of nonimmune donors and  of donors immunized with 3.5  X  106 
SRBC, recipient spleens with ~> 200 direct and  > 100 indirect PFC were scored as positive. 
For marrow grafts of donors immunized with 5  X  10 s  SRBC,  spleens with  ~>150 direct 
PFC and > 100 indirect PFC were scored as positive. 
:~ Geometric mean ±  standard error. Standard errors were calculated only for means of 
six or more individual values. 
§ Numbers in brackets indicate the number of mice in the groups. 1126  ANTIGEN-SPECIFIC MARROW  CELLS 
responses. Using the sign test (19) to compare the percentage of positive spleens 
for the two classes of PFC, a x2 value of 5.14 was obtained.  For one degree of 
freedom, the differences were statistically significant (P  <  0.05). These results 
confirmed earlier  experiments  in which nonimmune  C3BF1 marrow cells were 
grafted  into  fully  syngeneic  recipients,  and  PFC  were  enumerated  by  the 
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Fro. 1.  Percentage of C3B10F1 recipient spleens positive for direct PFC (symbol, •  ) and 
indirect PFC (symbol, O) after irradiation and injection with 5 X  107 syngeneic thymocytes, 
5 X  l0  s SRBC, and graded numbers of marrow cells. Sample sizes for each point are shown in 
Table  I. In the middle and  lower sections, symbols indicate  observed percentages and the 
computer fitted curves expected percentages according to the Poisson model. The numbers of 
transplanted  marrow cells for 63% positive spleens are indicated  by dashed  straight  lines. 
They contain, on the average, one detectable precursor unit limiting the immune responses 
studied. 
original Jerne plaque assay in dishes (21, 22). The non-Poisson distribution  and 
the unequal frequencies  of the  two PFC  responses suggested that  potentially 
immunocompetent cells of C3BF1 marrow were class differentiated and hetero- 
geneous for other properties as well. PFC may have been generated via a multi- 
plicity  of  cell-to-cell  interactions,  conceivably  by  marrow  cells  in  different 
stages  of differentiation  and maturation. 
A  total of 206 mice were grafted with marrow  cells from C3BF1 donors im- 
munized with 3.5 )<  10  ° SRBC, in three experiments.  As in the preceding  limit- HAROLD  C.  MILLER  AND  GUSTAVO  CUDKOWICZ  1127 
ing dilution assay, the proportion of recipient mice with spleens  positive for 
PFC was a function of the number of marrow cells  grafted (middle sections of 
Table I  and Fig. 1). The frequencies of indirect PFC responses  and the mean 
number  of indirect PFC  per positive spleen  were  unaffected by donor pre- 
imnmnization. In sharp contrast, the yield of direct PFC responses was changed 
by donor preimmunization so that their distribution conformed to the Poisson 
model. The close fit of the observations to the theoretical Poisson curve sub- 
stantiated this selective change within the marrow cell population. The calcu- 
lated probability value (P) for an inoculum of 106 marrow cells to produce posi- 
tive spleens for direct PFC was 2.91 with 95 % confidence intervals of 2.34-3.58. 
According to Poisson statistics, the inoculum size required for 63 % of the re- 
cipient spleens to be positive (DP), contains on the average one marrow cell or 
unit limiting PFC production. This inoculum size DP is the reciprocal of P  or 
1/P. Hence, 3.4 X  105 primed marrow cells (with 95 % confidence intervals of 
2.7-4.3)  contained on the  average one detectable precursor unit  interacting 
with thymocytes and generating direct PFC. 
A total of 133 mice were grafted with marrow cells from C3BF1 or C3B10F1 
donors immunized with the higher number of 5 X  108 SRBC, in two experiments 
(lower sections of Table I  and Fig. 1). In this assay, it was the frequency dis- 
tribution of indirect PFC responses that changed upon donor immunization, to 
conform to the Poisson model. The probability value for 106 cells to yield posi- 
tive recipient spleens for indirect PFC was 1.78  with 95 % confidence intervals 
of 1.38-2.28. Consequently, the inoculum size containing an average of one pre- 
cursor unit was 5.6 X  105 ceils with 95 % confidence intervals of 4.4-7.2. The 
frequencies of direct PFC responses were considerably lower in several groups 
of this limiting dilution assay than in the two preceding assays with marrow 
cells from nonimmune donors and donors immunized with a smaller number of 
SRBC. Only the highest numbers of 2  and 4  X  106 grafted cells from fully 
primed donors gave rise to direct PFC in 60--90% of recipients. The absence 
of direct IgM PFC in spleens of mice receiving the smaller marrow inocula may 
have resulted from inhibition by cells differentiating along the pathway leading 
to indirect (IgG) PFC, or by other marrow cells of primed mice. In turn, the 
inhibition could have been effected by cells themselves or by minute amounts 
of IgG antibody. 
Inhibition  of Direct PFC Responses by Marrow Cells of Primed Mice.--The 
competence of marrow cells and admixed thymocytes from nonimmune donors 
for direct PFC production was tested in the presence of primed marrow cells. 
Irradiated  C3B10Fi  mice were  injected  with  5  X  10  7  thymocytes,  10 6 marrow  cells from 
donors primed with 5  X  10  8 SRBC,  and graded numbers of marrow cells from noniramune 
donors, in a  range extending from 3.1 X  10  4 to 10  c. All donors and recipients were syngeneic. 
After 1 day, each animal was given 5 X  10  8 SRBC; direct and indirect PFC were enumerated 
9  days after transplantation. 1128  ANTIGEN-SPECIFIC MARROW CELLS 
All recipient spleens contained relatively large numbers of indirect PFC, pre- 
sumably because precursors of the two marrow cell populations, grafted along 
with  thymocytes, were  additive in generating PFC  (Table II).  Few spleens 
contained direct  PFC.  This was  anticipated since  106  primed marrow  cells 
grafted by themselves generated direct PFC in no more than 16 % of recipients 
(Table I, lower section), and may  have contributed cells capable of inhibiting 
direct PFC production by precursors of the nonimmune marrow. Direct  PFC 
were found in spleens of only 8  of 46 recipient mice (17 %), whereas  indirect 
PFC were found in spleens of 42 (Table II). Of the eight direct PFC responses, 
three were barely above control values. Among comparable recipients of thymo- 
cytes and nonimmune marrow cells (without added primed cells), direct PFC 
TABLE II 
Percentage of Recipient  Spleens Positive for Anti-Sheep  PFC After Infusion of 5  X  10  7 
Thymocytes, 5 X  IO  s SRBC, 10  6 Anti-SRBC Immune Marrow Cells, and Graded 
Numbers of Nonimmune  Marrow Cells 
Direct PFC  Indirect PFC 
No.  of  nonim- 
munc marrow  Fraction  of  Percentage No. of PFC per positive Percentage No. of PFC per positive  ceils transplanted  positive  of positive  of positive  spleen~t  spleens*  spleens*  spleen  spleens* 
(× t05) 
0.31  0/6  0  100  1363 q-  1017 
0.62  1/8  13  200  88  366  ±  91 
1.25  3/10  30  350, 320, 360  100  405  +  205 
2.50  2/11  18  200, 205  73  444  ±  200 
10.00  2/11  18  345, 1065  100  511  ±  247 
* Recipient spleens with >200 direct and > 100 indirect PFC were scored as positive. 
~/Geometric mean q- standard error. 
responses were found in 58 of 76 mice (76%, Table I). The results indicated that 
production of direct PFC by normal marrow cells was inhibited by l0  s added 
primed marrow cells. This experiment, however, could not provide information 
on the mechanism of the inhibitory effect. 
Frequency  of  Anti-Chicken  PFC  Responses  in  Mice  Injected  with  Graded 
Numbers of Marrow Cells.-- 
Groups of irradiated C3B10F1 mice were injected with a mixture of syngeneic cells consist- 
ing of 5 X  10  ~' thymocytes (from nonimmune donors) and graded numbers of marrow cells, in 
a range extending from 3.1  X  10  4 to 2 X  106. Marrow ceils were taken from two different 
groups of donors: nonimmune mice, or mice injected 4 months earlier with 5 X  108 sheep 
erythrocytes. 1 day after transplantation,  each animal was given 5 X  108 chicken erythro- 
cytes. Hemolytic anti-chicken PFC were enumerated in recipient spleens on the  9th  day. 
Spleens of 39 control mice given either marrow or thymus cells with CRBC contained less 
than 200 direct and 100 indirect anti-chlcken PFC, regardless of whether the marrow donors 
were immunized against antigens of SRBC. The results are presented in Table III and Fig. 2. HAROLD  C.  MILLER  AND  GUSTAVO  CUDKOWICZ  1129 
A  total of 114 mice were grafted with marrow cells from nonimmune donors 
in three experiments. As the number of marrow cells was increased, the propor- 
tion of recipients with positive spleens increased for direct and indirect PFC. 
Spleens were  either positive for  both types  of  PFC  or for  direct PFC  only. 
Therefore, the direct PFC responses were more frequent. The mean number of 
PFC  per  positive spleen did  not increase with  the  number of  marrow  cells 
grafted, as in limiting dilution assays for anti-sheep responses. The distribution 
of positive spleens in the different treatment groups followed closely the predic- 
TABLE III 
Percentage of Recipient Spleens  Positive for Anti-Chicken PFC After Infusion of 5  X  10  7 
Thymocytes,  5 X  10  8 CRBC, and Graded Numbers of Marrow Cells 
Direct PFC  Indirect PFC 
No. of marrow  Percentage of 
cells transplanted  Percentage of  No. of PFC per  No. of PFC per 
positive spleens*  positive spleeM:  positive  positive spleen~:  spleens* 
(X 105) 
Nonimmune marrow donors 
0.31  0  (9)§  --  0  -- 
0.62  9  (11)  265  0  -- 
1.25  35  (20)  722  4-  313  15  202 
2.50  52  (23)  501  4-  82  35  290  4-  181 
5.00  69  (26)  608  4-  86  42  467  4-  123 
10.00  93  (15)  646  4-  168  80  410  4-  126 
20.00  100  (10)  842  4-  144  80  321  4-  134 
Marrow donors injected with 5 X  10  s SRBC 
0.62  17  (6)  415  0  -- 
1.25  29  (17)  742  18  455 
2.50  56  (16)  635  4-  154  38  403  4-  99 
5.00  78  (14)  660  4-  209  50  430  4-  184 
10.00  93  (16)  1155 +  174  81  440  4-  140 
20.00  100  (10)  953  4-  221  80  312  4-  136 
* Recipient spleens with  >  200 direct and  >  100 indirect PFC were scored as postive. 
Geometric mean 4- standard error. Standard  errors were calculated only for means of 
six or more individual  values. 
§ Numbers in brackets indicate the number of mice in the groups. 
tions of the Poisson model (Fig. 2). The probability values for direct and in- 
direct PFC responses per unit number of  106 grafted marrow cells were 2.52 
and 1.24, respectively. The 95 %  confidence intervals did not overlap (Fig. 2). 
The inoculum sizes containing an average of one precursor unit were 3.9 X  105 
marrow cells (with 95 %  confidence intervals of 3.0--5.4) for direct PFC, and 
8.1  M  10  ~ cells (with 95 %  confidence intervals of 5.9-11.2) for indirect PFC. 
It was  remarkable that  the numbers of precursor units for  anti-chicken and 
anti-sheep PFC responses were so close, though donors were not primed for the 
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Most likely this is a coincidence. It must be noted that anti-chicken and anti- 
sheep PFC responses by nonimmune marrow cells differed with respect to the 
shape of the limiting dilution plots, which conformed to the Poisson model for 
the former but not for the latter responses. This suggested that at least one of 
the bone marrow cells required for PFC production was antigen specific. 
In two other experiments,  a  total of 79 mice were grafted with marrow cells 
from donors immunized against SRBC. The anti-chicken PFC responses were 
undistinguishable  from the responses elicited  by marrow cells  of mice not in- 
jected  with  SRBC,  both  with  regard  to  frequencies  of positive  spleens  and 
numbers of PFC per spleen  (compare upper and lower sections of Table III). 
I  O0 ~  Anh-ch/cken  PFC 
10  4  10  5  10  6  t0  7 
Number of Transplanted Marrow Cells 
Fro. 2.  Percentage  of CSB10F1 recipient spleens  positive for direct PFC  (closed symbols) 
and indirect  PFC  (open symbols) after  irradiation  and  injection  with  5 X  107 syngeneic 
thymocytes,  5 X  l0  s CRBC, and graded numbers of marrow cells. Donors of marrow cells 
were either untreated  mice (symbols, •  and O) or mice injected 4 months earlier with 5 X  l0  s 
SRBC (symbols, •  and A). Sample sizes for each point are shown in Table III. Symbols indi- 
cate observed percentages and curves expected percentages according to the Poisson model. 
The curves were computer fitted to the pooled percentages of positive spleens in recipients of 
nonimmune and immune (anti-SRBC) marrow cells. The P values were 2.71 (95% confidence 
intervals,  2.16-3.36) for direct  PFC, and 1.29 (95% confidence intervals,  1.01-1.62) for in- 
direct PFC. The numbers of transplanted  marrow cells containing on the average one detect- 
able precursor unit are indicated by the dashed straight lines. 
Accordingly, the calculated probability values for positive anti-chicken spleens 
per  106 marrow  cells  did  not  differ significantly  for the  two kinds  of donors 
(Fig.  2).  The effects  of SRBC priming were  apparently  restricted  to marrow 
cells  engaged  in  anti-sheep  responses.  The  production  of direct  anti-chicken 
PFC  was not  inhibited  upon transplantation  into  irradiated  mice  of marrow 
cells from donors immunized against SRBC. Cells of such marrow strongly in- 
hibited  the  production of direct  anti-sheep  PFC under identical experimental 
conditions (Table I, lower section). Hence, SRBC immunization induced func- 
tional changes in a  subpopulation  of bone marrow cells endowed with antigen 
specificity. 
DISCUSSION 
The peculiar organ distribution of potentially immunocompetent cells in the 
mouse has proven to be of great  advantage for understanding  cellular mecha- HAROLD  C.  MILLER  AND  GIISTAVO  CUDKOWICZ  1131 
nisms and controls of antibody formation. The advantage stems from natural 
separation of cells endowed with distinct functions in thymus and bone marrow. 
Thus, the thymus contains and releases  ARC, i.e., cells which react with anti- 
gens in vivo and in vitro during an early phase of the immune response (3, 5, 
6, 9-12).  Subsequently, ARC proliferate and generate inducer cells,  i.e., cells 
capable of interacting with marrow derived cells and of inducing specific anti- 
body formation (11).  Although thymus-derived cells are not engaged directly 
in synthesis of immunoglobulins (23,  1), their function as inducers is essential 
for bone marrow-derived cells to produce specific antibodies against a variety 
of  naturally  occurring  and  synthetic  antigens  (1-3,  8,  24).  The  induction 
process requires the presence of viable inducer cells (12) and of the antigens that 
have initiated the immune response by reacting with ARC (10-12). Therefore, 
antigens play an essential role during at least two discrete events (11).  Bone 
marrow contains and releases cells which do not share with thymic ARC the 
same kind of antigen reactivity, so that the former cells cannot substitute for 
thymocytes in  early events of immune responses  (11).  The  possibility that 
marrow cells are antigen reactive or antigen sensitive in some other way has 
not been excluded. However, such functional properties would have to be recog- 
nized by manifestations different from those elicited by ARC. The best known 
function of marrow-derived cells is the synthesis of antibody molecules (1-3, 6). 
Several lines of evidence suggest that cells with other accessory immune func- 
tions, yet to be defined, are also derived from bone marrow (5, 6, 21, 22, 25). 
Genetic information concerning molecular class of immunoglobulins is expressed 
differentially in marrow-derived cells  (precursor or accessory cells)  but not in 
thymic ARC (11, 21, 22). 
Little is known about the respective role of thymus- and marrow-derived cells 
in the determination of other properties of antibody to be synthesized by ma- 
ture immunocytes. Of primary interest are the controls of antibody specificity 
and the related cross-reactivity and affinity  for antigens. Inducer cells of thymic 
origin are  antigen specific  (10-12).  Commitment to given antigenic determi- 
nants may have preexisted exposure to  antigens in the ARC, or may have 
arisen as a consequence of reaction with antigens. The first possibility is gen- 
erally preferred, primarily because induced specific unresponsiveness is rather 
difficult to understand under the assumption that ARC are not capable of dis- 
criminating among antigenic determinants. In fact, several experiments have 
indicated that tolerogenic treatments of mice incapacitate thymus-derived cells 
in a  specific  way, i.e.  without affecting either the ability of marrow cells  to 
participate in immune reactions against the same antigens, or the competence 
of both thymus and marrow cells for reactions against other antigens (7-9). 
This type of evidence, though suggestive, falls short of formally proving antigen 
specificity of thymic ARC prior to immunization, since other cell types involved 
in primary antigen handling could have been the targets of tolerogenic treat- 
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of fact (10-12); hence, one can conclude that one of the sources of specificity 
restriction  for  mature  antibody-forming  cells  has  to  be  traced  to  thymus- 
derived inducers. Then, the pertinent question is whether there are other sources 
of information for antibody specificity, e.g., in marrow cells, or whether thymus 
derived inducer cells have to confer specificity upon uncommitted precursors of 
immunocytes by transfer of information. 
Two  experimental  approaches  were  used  to  investigate  whether  marrow- 
derived cells are antigen specific: (a) anti-sheep and anti-chicken primary PFC 
responses elicited by limiting  numbers  of transplanted marrow cells  (in  the 
presence of excess thymocytes) were compared with regard to shape and posi- 
tion of limiting dilution plots; (b)  anti-sheep and anti-chicken PFC responses 
elicited by marrow cells from donors immunized against SRBC  (with the co- 
operation of nonimmune thymocytes), were compared with primary responses 
to identify specific changes in marrow cells. The primary anti-SRBC and anti- 
CRBC responses by marrow cells of C3B10F1 mice differed sharply from each 
other under the conditions of limiting dilution assays. Furthermore, immuniza- 
tion of marrow donors against antigens of SRBC altered the population of cells 
engaged  in  PFC  responses  to  SRBC  but  not  that  engaged  in  anti-CRBC 
responses. 
Limiting dilution analysis is a method for studying the frequency, function, 
and potential of the least frequent cell type of a heterogeneous population of 
cells participating in an immune response. In cell transfer systems, irradiated 
test  animals can be provided with  an excess of all required cell types, while 
limiting the availability of one (11, 13, 14, 21, 22, 24). If an antibody response 
depends entirely on the presence or absence of the rarest cell type or functional 
unit  of cells  (all other cells or events being nonlimiting), the  distribution  of 
immune responses among mice given graded numbers of limiting cells will  be 
dictated by Poisson statistics.  Conditions such  as  these were established by 
transplanting into several groups of irradiated mice 5  X  107 thymocytes with 
graded  numbers  of marrow  cells.  The distribution  of  anti-chicken  PFC  re- 
sponses in the various treatment groups conformed to the expectations of the 
Poisson model, indicating that the assumptions made in designing the experi- 
ments (21,  22) were presumably correct. The most important assumption con- 
cerned the existence in marrow of a cell type which alone limited the occurrence 
of an event essential for PFC formation. Such an event could have been cell-to- 
cell interaction with thymus derived inducer cells or with other marrow derived 
accessory cells.  This  assumption  does  not  restrict  the  number  of cells with 
distinct functions which may participate in immune responses during discrete 
subsequent events.  It  requires, however, that  one of the cell types  and one 
event limit PFC production. 
The distribution of primary anti-sheep PFC responses in recipients of graded 
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Poisson model. These results indicated that the  assumptions made were not 
correct for marrow cells engaged in formation of anti-sheep PFC, although they 
were  correct for marrow  cells producing  anti-chicken PFC.  If marrow con- 
rained several types of potentially immunocompetent cells participating in a 
multiplicity of cell-to-cell interactions, each one limiting anti-sheep PFC pro- 
duction, one would expect non-Poisson limiting  dilution plots. Whatever the 
interpretation of the plots, certain types of marrow cells,  precursors of PFC 
(P-PFC), accessory cells, or both, were antigen specific since their function was 
expressed differentially during responses to SRBC and CRBC. Although  the 
present data gave no indication of the functional cell type which was  antigen 
specific, nor of the proportion of unispecific cells, they ruled out the possibility 
that the same cells effected anti-SRBC and anti-CRBC responses. The results 
were consistent with the observations of Playfair (26) : in the fetal liver of NZB 
mice there were more P-PFC for SRBC than for CRBC, while in the liver of 
BALB/c mice the numbers of the two types of P-PFC were similar. Thus, the 
existence of antigen-specific ilnmunocompetent cells  other than those derived 
from thymus  was  strongly suggested by qualitative  as  well  as  quantitative 
differences between cells engaged in anti-SRBC and anti-CRBC responses. 
The second approach to demonstrate antigen specificity in marrow derived 
cells made use of SRBC-immune donor mice. Marrow cells of such donors, co- 
operating with normal thymocytes, were undistinguishable  from nonimmune 
marrow cells in anti-chicken PFC responses. In contrast, specifically immune 
marrow cells differed markedly from nonimmune cells in anti-SRBC responses: 
the frequencies of positive spleens after transplantation of limiting numbers of 
marrow cells and 5  X  l0  T nonimmune thylnocytes conformed to the Poisson 
model; and immune marrow cells specifically inhibited direct PFC production. 
The conversion of shallow limiting dilution plots to Poisson plots (Fig. 1) indi- 
cated  that  antigen-dependent  differentiation  or  maturation  occurred  after 
SRBC injection, so as to drive into a particular functional state the heteroge- 
neous population of potentially immunocompetent marrow cells of nonimmune 
mice. As a result, PFC responses depended on the availability of one critical 
cell type, the rarest, participating in a single-hit event. The data gave no indi- 
cation of which cell types, P-PFC or accessory cells, underwent differentiation 
or maturation. It was of interest that immunization of marrow donors with the 
suboptimal number of 3.5  X  106 SRBC did not induce functional changes in 
precursor units of indirect PFC, while it did in precursor units of direct PFC. 
Dissociation of the two responses with regard to the shape of limiting dilution 
plots strengthened the interpretation of earlier experiments according to which 
marrow precursor units of PFC are restricted for the molecular class of anti- 
body to be made by descendent PFC (21, 22). Since limiting dilution plots for 
anti-CRBC  responses conformed to the Poisson model regardless of whether 
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rule out the possibility that antigen-dependent differentiation or maturation of 
marrow cells was nonspecific, or affected cell types with functions not related to 
antibody  specificity. Limiting  dilution  assays  for  anti-SRBC  responses  by 
marrow cells of mice immunized with non cross-reacting antigens are underway, 
and preliminary results suggest that this is not the case. 
Immunization of marrow donors with the optimal number of 5 X  l0  s SRBC 
gave rise to cells which either inhibited precursors of direct PFC by cell-to-cell 
interactions, or by diffusable substances. In view of the specificity of inhibition 
(not detected in anti-CRBC  responses),  and  of the small number of primed 
marrow cells  required  (106 cells per  recipient),  it is  most likely that  minute 
amounts of IgG antibody released by differentiating cells inhibited direct PFC 
production (27, 28). The mechanism of direct P-PFC inhibition, although inter- 
esting in its own merit, was not of importance in the present studies. The speci- 
ficity of the inhibition effect constituted evidence for the existence in mouse 
marrow of another antigen-specific and antigen-sensitive cell, perhaps involved 
in regulation of antibody responses. 
In conclusion, bone marrow of mice contains antigen-specific and antigen- 
sensitive  cells  detectable  in  experimental  systems  involving  immunization 
against SRBC. Possibly, marrow cells of more than one functional type are en- 
dowed with these properties, since their existence was demonstrated by antigen- 
dependent differentiation or maturation of precursor units, and by the appear- 
ance of cells responsible for inhibition of direct PFC production. In studies of 
others, evidence for the existence of antigen-specific marrow cells is as follows: 
(a) certain humoral antibody responses are not dependent on marrow-thymus 
cell cooperation and can be elicited by marrow calls transplanted by themselves 
into irradiated mice (29) ; (b) genetic low responder mice to the syntheti  c poly- 
peptide antigen (T, G)-Pro-L are defective in marrow-derived cells cooperating 
with thymocytes for this particular immune response (24). The defective pheno- 
type, correctable by administration of the synthetic ribonucleotide poly A: U, 
is determinant specific. For all these evidences it can be postulated that transfer 
of informational molecules from thymus-derived to marrow-derived cells may 
not be required for a  model describing specificity differentiation of immuno- 
cytes. In fact, marrow cells appear to be antigen specific prior to engagement in 
cell-to-cell interactions. 
SIYMMARY 
Graded numbers of marrow cells and 5 X  107 thymocytes were mixed in vitro 
and transplanted  into X-irradiated (C3H X  C57BL/10)F1 mice. Upon injec- 
tion  of sheep or  chicken  erythrocytes, splenic  plaque-forming cells secreting 
IgM (direct PFC) or IgG (indirect PFC) hemolytic antibody were enumerated 
at the time of peak responses. 
Anti-sheep and anti-chicken primary PFC responses elicited by nonimmune 
marrow cells differed sharply from each other under the conditions of limiting HAROLD  C.  MILLER  AND  GUSTAV0  CUDIKOWICZ  1!35 
dilution  assays. The frequencies of anti-chicken responses in recipients  of dif- 
ferent  numbers of marrow cells  conformed to the  predictions  of the  Poisson 
model, while the frequencies of anti-sheep responses did not. Hence, the func- 
tion  of  certain  marrow-derived  cells  was  expressed  differentially  during  the 
two  immune  responses,  to  exclude that  the  same precursor  units  generated 
anti-sheep or anti-chicken PFC. The former precursor cells or units were func- 
tionally more heterogeneous than the latter. 
Immunization  of marrow  donors  against  sheep  erythrocytes  did  not  alter 
the population of cells engaged in anti-chlcken responses, since limiting dilution 
assays with immune and nonimmune marrow cells gave identical results. How- 
ever, anti-sheep  irmnunization altered specifically the cell populatio  n  engaged 
in anti-sheep  responses,  in two ways: (a)  potentially immunocompetent mar- 
row  cells  underwent  antigen-dependent  differentiation  or maturation,  to be- 
come  functionally  homogeneous.  Consequently,  the  frequencies  of  PFC  re- 
sponses in limiting dilution assays conformed to the Poisson model; the changes 
occurred  independently  in  class-restricted  precursors  of  direct  and  indirect 
PFC.  (b)  marrow  cells  capable  of  inhibiting  precursors  of  direct  anti-sheep 
PFC arose in primed mice. The inhibition,  which was specific, could have been 
effected directly by marrow cells or by a  diffusable product such as IgG anti- 
body.  Results  indicated  that  potentially  immunocompetent  cells .bf  mouse 
marrow with distinct functions were antigen specific and antigen sensitive. 
Note Added in Proof: After submission of the manuscript,  we read two new publications 
describing the existence of antigen-specific and antigen-sensitive cells in mouse bone marrow. 
Such cells were incapacitated  by tolerogenic treatment~ in vivo  (30) and sensitized by im- 
munization (31). 
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